Researchers discussed preclinical models and drug development for neuromuscular disorders (NMDs) in a panel discussion held at WMS2020.
Highlights of the discussion were as follows:
News
News
Daily digests from key neurology conferences, written by on-site medical journalists.
Published: 01 Oct 2020